BC-7013
Modify Date: 2025-10-31 23:37:29
BC-7013 structure
|
Common Name | BC-7013 | ||
|---|---|---|---|---|
| CAS Number | 1028291-66-8 | Molecular Weight | 500.69 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H40O5S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BC-7013BC-7013 is a novel semi-synthetic pleuromutilin derivative. BC-7013 has excellent activity against Gram-positive pathogenic bacteria. BC-7013 exhibits potent antibacterial properties against both Staphylococcus, Streptococcus and penicillin-resistant Streptococcus pneumoniae. BC-7013 has activity against Gram-positive pathogenic bacteria, BC-7013 is useful in the research of acute bacterial skin and skin structure infection (ABSSSI)[1]. |
| Name | BC-7013 |
|---|
| Description | BC-7013 is a novel semi-synthetic pleuromutilin derivative. BC-7013 has excellent activity against Gram-positive pathogenic bacteria. BC-7013 exhibits potent antibacterial properties against both Staphylococcus, Streptococcus and penicillin-resistant Streptococcus pneumoniae. BC-7013 has activity against Gram-positive pathogenic bacteria, BC-7013 is useful in the research of acute bacterial skin and skin structure infection (ABSSSI)[1]. |
|---|---|
| Related Catalog | |
| Target |
MIC50: 0.015µg/mL (303 tested S. aureus isolates)[2] |
| References |
| Molecular Formula | C29H40O5S |
|---|---|
| Molecular Weight | 500.69 |
| InChIKey | KELRBTWVTDHIHS-KGTFJIFRSA-N |
| SMILES | C=CC1(C)CC(OC(=O)CSc2cccc(CO)c2)C2(C)C(C)CCC3(CCC(=O)C32)C(C)C1O |